Corporate News: Edwards Lifesciences (EW)
Trading performance
Edwards Lifesciences shares increased by 0.12 % during the 24‑hour period ending at 08:34 AM Central Europe on Thursday 22 Oct 2026.
The current trading price is USD 88.40 on major exchanges.
Market metrics
Shares outstanding: 575.8 million.
Market capitalization: USD 50.9 billion.
Volume: USD 240.2 million worth of shares traded in the last 24 hours.
Price trend: down 0.43 % since the end of last month.
Simple moving average (200 days): USD 85.18.
52‑week range: highest at USD 96.29 (07 Jul 2026); lowest at USD 74.66 (02 Nov 2026).
Peer comparison (last 24 hours)
| Company | Ticker | Price change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Paccar | PCAR | +0.14 % | USD 110.22 | USD 57.9 bn | 23.12 |
| Fastenal | FAST | +1.63 % | USD 52.49 | USD 60.2 bn | 42.12 |
| Mplx | MPLX | +0.09 % | USD 58.44 | USD 59.2 bn | 12.5 |
| Natera | NTRA | +1.84 % | USD 413.38 | USD 58.5 bn | — |
| Cardinal Health | CAH | –0.03 % | USD 257.46 | USD 59.6 bn | 35.37 |
- Company profile Edwards Lifesciences Corporation is a health‑care equipment and supply company that specializes in products and services for treating late‑stage cardiovascular disease. Its product line includes tissue replacement heart valves, heart valve repair devices, hemodynamic monitoring equipment, angioscopy instruments, oxygenators, and pharmaceuticals. The company distributes its products globally and is listed on the New York Stock Exchange.
